NYSE:SNY - Sanofi Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$41.48 -0.57 (-1.36 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$41.48
Today's Range$41.3033 - $41.79
52-Week Range$37.43 - $45.86
Volume759,428 shs
Average Volume894,602 shs
Market Capitalization$108.88 billion
P/E Ratio13.25
Dividend Yield2.85%
Beta0.67
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$39.60 billion
Cash Flow$4.5582 per share
Book Value$26.11 per share

Profitability

Net Income$4.28 billion

Miscellaneous

Employees106,566
Outstanding Shares2,508,088,000
Market Cap$108.88 billion
OptionableOptionable

Sanofi (NYSE:SNY) Frequently Asked Questions

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

How often does Sanofi pay dividends? What is the dividend yield for Sanofi?

Sanofi declared an annual dividend on Tuesday, February 13th. Investors of record on Thursday, May 10th will be paid a dividend of $1.8609 per share on Monday, June 4th. This represents a yield of 4.72%. The ex-dividend date is Wednesday, May 9th. This is a positive change from Sanofi's previous annual dividend of $1.58. View Sanofi's Dividend History.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) issued its quarterly earnings data on Wednesday, October, 31st. The company reported $1.07 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.09. The firm earned $9.39 billion during the quarter, compared to analyst estimates of $9.10 billion. Sanofi had a net margin of 12.20% and a return on equity of 18.18%. The company's quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the business earned $1.71 EPS. View Sanofi's Earnings History.

When is Sanofi's next earnings date?

Sanofi is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Sanofi.

What price target have analysts set for SNY?

14 Wall Street analysts have issued 12 month price objectives for Sanofi's shares. Their forecasts range from $45.00 to $55.00. On average, they anticipate Sanofi's share price to reach $50.00 in the next twelve months. This suggests a possible upside of 20.5% from the stock's current price. View Analyst Price Targets for Sanofi.

What is the consensus analysts' recommendation for Sanofi?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sanofi.

Has Sanofi been receiving favorable news coverage?

News stories about SNY stock have trended somewhat negative recently, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sanofi earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term.

Are investors shorting Sanofi?

Sanofi saw a drop in short interest in December. As of December 31st, there was short interest totalling 1,952,491 shares, a drop of 33.4% from the December 14th total of 2,931,545 shares. Based on an average trading volume of 1,052,853 shares, the days-to-cover ratio is currently 1.9 days. Approximately 0.1% of the company's stock are sold short. View Sanofi's Current Options Chain.

Who are some of Sanofi's key competitors?

Who are Sanofi's key executives?

Sanofi's management team includes the folowing people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 53)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Hamlin Capital Management LLC (0.08%), Foundation Resource Management Inc. (0.01%), Beacon Financial Group (0.00%), Cullinan Associates Inc. (0.00%), Cardinal Capital Management (0.00%) and Gradient Investments LLC (0.00%). View Institutional Ownership Trends for Sanofi.

Which major investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Hamlin Capital Management LLC, Gradient Investments LLC, Beacon Financial Group, Cullinan Associates Inc., Macnealy Hoover Investment Management Inc., Thomasville National Bank, E&G Advisors LP and Fulton Bank N.A.. View Insider Buying and Selling for Sanofi.

Which major investors are buying Sanofi stock?

SNY stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Quadrant Capital Group LLC, Lourd Capital LLC, Cardinal Capital Management, Legacy Financial Advisors Inc., Moody National Bank Trust Division, Foundation Resource Management Inc. and CENTRAL TRUST Co. View Insider Buying and Selling for Sanofi.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $41.48.

How big of a company is Sanofi?

Sanofi has a market capitalization of $108.88 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis. Sanofi employs 106,566 workers across the globe.

What is Sanofi's official website?

The official website for Sanofi is http://www.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]


MarketBeat Community Rating for Sanofi (NYSE SNY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  379 (Vote Outperform)
Underperform Votes:  482 (Vote Underperform)
Total Votes:  861
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel